Patent · US Active

Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof

US8771745B2 · kind B2 · utility

2Cited by

11References

1Claims

0Family size

Assignee

Allergan, Inc. · US

Inventors

Michael R. Robinson · Irvine, US
Hui Liu · Lanzhou, CN
Patrick M. Hughes · Aliso Viejo, US
Lon T. Spada · Walnut, US
Alazar N. Ghebremeskel · Irvine, US

Key dates

Filing date	Aug 28, 2012
Grant date	Jul 8, 2014
Priority date	—
Expiry date	Aug 28, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P27/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Biocompatible, bioerodible implants and microspheres include latanoprost and a biodegradable polymer effective, when placed intraocular (such as into the subtenon space) to treat glaucoma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.